Serial Number
99281840
Owner
Memorial Sloan-Kettering Cancer CenterAttorney
Natasha ReedFirst Use Date
Dec 31, 1988
Filing Date
Jul 14, 2025
MSK Trademark
Serial Number: 99281840
Trademark Classes
Class 36 - Insurance & Financial
Insurance; financial affairs; monetary affairs; real estate affairs
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
Natasha Reed FOLEY HOAG LLP
1301 Avenue of the Americas
25th Floor
New York, NY 10019
United States
Trademark Details
Filing Date
July 14, 2025
Registration Date
Not Registered
First Use Anywhere
December 31, 1988
First Use in Commerce
December 31, 1988
Goods & Services
Educational services, namely, training clinicians and healthcare providers in analysis of clinical data utilizing diagnostic, clinic-genomic, and harmonized oncologic dataset and database models pertaining to cancer outcome predictions and treatment recommendations; Educational services, namely, conducting community lectures on cancer and related health issues, and distribution of related informational materials therewith; Educational services, namely, conducting classes, seminars, training programs, correspondence courses, and scientific conferences via television, radio, and global computer networks, all in the fields of medicine and biomedical sciences.
Charitable fundraising services by means of raising money for cancer research, cancer treatment, cancer awareness and the construction of facilities for use in cancer research, cancer treatment and cancer awareness.
Research in the biomedical sciences fields, including molecular biology, cell biology, genetics, and immunology; medical services; Healthcare services for treating cancer; Hospital services, namely, patient treatment and care; Pharmaceutical prescription formulation being compounding, and dispensing services; Providing medical services in the nature of patient consultations and medical information via telemedicine; Medical initiative and research and development services pertaining to the development of cancer vaccines that target neoantigens; Scientific research services in the biomedical sciences fields, including molecular biology, cell biology, genetics, and immunology; Compiling medical data for research purposes in the field of gene mutations in rare and common cancers for evaluation and assessing tumor biology, prognosis, and treatment and patient drug response; Providing non-downloadable on-line software, software applications, software tools, and databases using natural language processing and machine learning algorithms, for extracting, characterizing, defining, annotating, curating, structuring, and communicating clinical information and health records; compiling medical data for research purposes.
Medical services; Healthcare services for treating cancer; Hospital services, namely, patient treatment and care; pharmaceutical prescription formulation being compounding, and dispensing services; providing medical services in the nature of patient health consultations for patients and providing medical information via telemedicine, videoconferencing, and teleconferencing software